Navigation Links
Free Access to Literature Data on Chagas' Disease Offered Online: Collaborative Drug Discovery, Inc. provides Neglected Disease researchers with 'archive mine and collaborate' access to small molecule bioactivity SAR data on parasitic disease
Date:10/17/2007

SAN FRANCISCO, Oct. 17 /PRNewswire/ -- Collaborative Drug Discovery, Inc. (CDD, Inc.) has captured extensive literature data from six years of recent publications focused on the fight against Chagas' disease. Now for the first time these data are available to researchers free of charge, via the CDD Database.

Sources include the Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry, the Journal of American Chemical Society, Journal of Ethnopharmacology, Proceedings of the National Academy of Sciences (PNAS), International Journal of Antimicrobial Agents, Bioorganic & Medicinal Chemistry Letters, European Journal of Medicinal Chemistry, Molecular and Biochemical Parasitology, Journal of Inorganic Biochemistry, Acta Topical, and Experimental Parasitology.

The data sets captured include 574 compound structures and just over 350 different enzyme, cell, animal, and toxicity based protocols. The data are conveniently organized so scientists can easily mine for hits, sub-structural motifs or keywords and obtain the original literature reference for more detailed analysis.

These data sets will help researchers better prioritize compounds to test experimentally and build superior models to guide experiments.

This project is the first of a series literature data capture projects focused on drug discovery research into neglected infectious diseases. In addition to literature data, community members also provide open access to some of their experimental results either pre- or post-publication. The CDD global community includes leading researchers from four continents.

To submit other datasets, capabilities, expertise, or models which would be valuable to the Chagas' or neglected disease community, please contact us at info@collaborativedrug.com.

A significant subset of all the community data -- and a range of other data sets such as Chagas' data -- is available openly to the public at no cost. For this historical set of data either visit http://www.collaborativedrug.com/registrations/new or e-mail info@collaborativedrug.com to register for the username and password to the open data sets.

About Collaborative Drug Discovery: CDD is the world's first platform for selectively sharing collaborative drug discovery data. Scientists working with the CDD community platform can pool their research in order to more effectively develop new drug candidates for commercial and humanitarian markets. Conceived in 2003, and formally launched in 2004, Collaborative Drug Discovery (CDD) has been serving the collaborative data needs of researchers for years. The CDD global community includes hundreds of scientists from leading research foundations, academia and industry. A subset of the data is available openly to the public at no cost. For more information, please visit http://www.collaborativedrug.com.


'/>"/>
SOURCE Collaborative Drug Discovery, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Controversial deal on public access of the human genome map
2. Health Canada Gave Access To Unapproved Drugs To AIDS/HIV Patients.
3. Health Care Disparities cause of inaccessibility to new technology
4. Scots Do Not Have Access To Proper Dental Care
5. Speedier Access To Advances In Breast Cancer Sought For Patients
6. Children In Scotland Denied Access To Dental Care
7. Patients Have Right To Access Medical Case Papers: Bombay High Court
8. AIDS Deaths On The Rise Due To Low Access To Antiretroviral Treatment
9. Easy Access To Healthcare Services Essential For Better Survival Rates
10. People Affected By HIV Positive Urge For Better Treatment Access
11. Singapore To Offer More Patients Access To Chronic Disease Management Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... ... 2017 , ... “The Inn at the Mill”: a story of love and redemption, hope ... become happy and content. , “The Inn at the Mill” is the creation of ... and Vermont and is now living in Berks County on Crow Hill. The ...
(Date:1/23/2017)... ... January 23, 2017 , ... “Some Infallible Characteristics of Christ”: a fascinating ... of Christ” is the creation of published author, Rev. Dr. Robert W. Thomas, the ... years, a preacher for over nineteen, a pastor for over fifteen years. He is ...
(Date:1/22/2017)... Viejo, California (PRWEB) , ... January 22, 2017 , ... ... Photo Cloud to create a beautiful 3D slideshow with complete ease," said Christina Austin ... the Generators browser to place in the FCPX timeline. Presets include scenes ...
(Date:1/21/2017)... California (PRWEB) , ... January 21, 2017 , ... "ProDOF is the perfect set of ... subject to another subject in a scene," said Christina Austin - CEO of Pixel Film ... given scene. Easily create the illusion of a DSLR racking focus from one area ...
(Date:1/21/2017)... ... 21, 2017 , ... Northern California Medical Associates (NCMA) is ... multi-specialty medical group. The dermatology practice provides general dermatologic treatment, outpatient surgery, clinical ... this excellent dermatology practice to our group’s medical services,” explains NCMA CEO, Ruth ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... 23, 2017  Delcath Systems, Inc. (NASDAQ: ... treatment of primary and metastatic liver cancers, today announced ... President and Chief Executive Officer of Delcath will be ... Markets, Thirteenth Annual Investor Conference at the Boca Raton ... , on Tuesday, January 31, 2017 at 10:30 ...
(Date:1/23/2017)... , Jan. 23, 2017 The American ... the Pharmacy and Medically Underserved Areas Enhancement ... of Representatives. The legislation, which was previously introduced in ... patient access to health care through pharmacists and their ... include Representatives Brett Guthrie (R-KY), G.K. ...
(Date:1/23/2017)... , January 23, 2017 Ahead of today,s ... see how they have fared at the close: Kite Pharma Inc. ... (NASDAQ: OVAS ), and Regeneron Pharmaceuticals Inc. (NASDAQ: ... shares were relative laggards on Friday, January 20 th , 2017, ... complimentary research reports on these stocks now at: ...
Breaking Medicine Technology: